These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
286 related items for PubMed ID: 16182711
1. Kidney transplantation from hepatitis B surface antigen-positive donors into hepatitis B surface antigen-positive recipients: preliminary findings. Veroux M, Puliatti C, Macarone M, Cappello D, Gagliano M, Spataro M, Di Mare M, Giuffrida G, Veroux P. Transplant Proc; 2005; 37(6):2467-8. PubMed ID: 16182711 [Abstract] [Full Text] [Related]
2. Kidney transplantation from donors with viral B and C hepatitis. Veroux P, Veroux M, Sparacino V, Giuffrida G, Puliatti C, Macarone M, Fiamingo P, Cappello D, Gagliano M, Spataro M, Di Mare M, Cannizzaro MA, Severino V. Transplant Proc; 2006 May; 38(4):996-8. PubMed ID: 16757242 [Abstract] [Full Text] [Related]
3. The effect of HBsAg-positivity of kidney donors on long-term patient and graft outcome. Berber I, Aydin C, Yigit B, Turkmen F, Titiz IM, Altaca G. Transplant Proc; 2005 Dec; 37(10):4173-5. PubMed ID: 16387070 [Abstract] [Full Text] [Related]
4. HBsAg(+) donor as a kidney transplantation deceased donor. Wei HK, Loong CC, King KL, Wu CW, Lui WY. Transplant Proc; 2008 Sep; 40(7):2097-9. PubMed ID: 18790163 [Abstract] [Full Text] [Related]
5. Cadaveric renal transplantation in hepatitis B antigen-positive recipients using hepatitis B antigen-positive donor organs with lamivudine treatment. Kim JA, Huh W, Lee KW, Kim SJ, Kim YG, Kim DJ, Joh JW, Oh HY. Transplant Proc; 2004 Jun; 36(5):1434-7. PubMed ID: 15251352 [Abstract] [Full Text] [Related]
6. Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage. Fabrizio F, Bunnapradist S, Martin P. J Nephrol; 2002 Jun; 15(6):605-13. PubMed ID: 12495272 [Abstract] [Full Text] [Related]
7. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors. Sumethkul V, Ingsathit A, Jirasiritham S. Transplant Proc; 2009 Jun; 41(1):213-5. PubMed ID: 19249516 [Abstract] [Full Text] [Related]
9. Use of hepatitis B core antibody-positive donor kidneys in hepatitis B surface antibody-positive and -negative recipients. Veroux M, Puliatti C, Gagliano M, Cappello D, Macarone M, Vizcarra D, Spataro M, Di Mare M, Ginevra N, Veroux P. Transplant Proc; 2005 Jun; 37(6):2574-5. PubMed ID: 16182748 [Abstract] [Full Text] [Related]
10. Use of kidney donors with hepatitis B, hepatitis C, or brain tumor: a single-center experience. Tatar E, Turan MN, Firat O, Sezer TO, Sozbilen M, Solak I, Toz H, Hoscoskun C. Transplant Proc; 2012 Jun; 44(6):1601-3. PubMed ID: 22841224 [Abstract] [Full Text] [Related]
11. Renal transplant in hepatitis B and C positive patients--a ten years experience. Rathod JR, Sirsat RA, Shah BV. J Assoc Physicians India; 2002 Jun; 50():766-70. PubMed ID: 12240839 [Abstract] [Full Text] [Related]
12. Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool. Donataccio D, Roggen F, De Reyck C, Verbaandert C, Bodeus M, Lerut J. Transpl Int; 2006 Jan; 19(1):38-43. PubMed ID: 16359375 [Abstract] [Full Text] [Related]
13. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection. Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH. J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883 [Abstract] [Full Text] [Related]
14. Reactivation of hepatitis and lamivudine therapy in 11 HBsAg-positive renal allograft recipients: a single centre experience. Murakami R, Amada N, Sato T, Orii T, Kikuchi H, Haga I, Ohashi Y, Okazaki H. Clin Transplant; 2006 Feb; 20(3):351-8. PubMed ID: 16824154 [Abstract] [Full Text] [Related]
15. Donor screening for hepatitis B virus infection in a cell and tissue bank. Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ. Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905 [Abstract] [Full Text] [Related]
16. Clinical outcome of renal transplantation in patients with positive pre-transplant hepatitis B surface antigen. Ahn HJ, Kim MS, Kim YS, Kim SI, Huh KH, Ju MK, Ahn SH, Han KH. J Med Virol; 2007 Nov; 79(11):1655-63. PubMed ID: 17854044 [Abstract] [Full Text] [Related]
17. Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series. Huang YW, Liu CJ, Lai MY, Lee PH, Tsai MK, Wang SS, Lai MK, Kao JH. Clin Ther; 2006 Sep; 28(9):1327-34. PubMed ID: 17062306 [Abstract] [Full Text] [Related]
18. Clinical outcome of renal transplantation in end-stage renal disease patients with positive pretransplantation hepatitis B surface antigen. Patel HV, Kute VB, Vanikar AV, Shah PR, Gumber MR, Jain SH, Engineer DP, Ghelani GH, Trivedi HL. Transplant Proc; 2012 Jan; 44(1):72-4. PubMed ID: 22310582 [Abstract] [Full Text] [Related]
19. Heart transplantation using donors positive for hepatitis. Wang SS, Chou NK, Ko WJ, Yu HY, Chen YS, Hsu RB, Huang SC, Chi NH, Tsao CI, Lai MY, Liau CS, Lee YT. Transplant Proc; 2004 Oct; 36(8):2371-3. PubMed ID: 15561252 [Abstract] [Full Text] [Related]
20. Lamivudine prophylaxis for hepatitis B virus infection after lung transplantation. Shitrit AB, Kramer MR, Bakal I, Morali G, Ben Ari Z, Shitrit D. Ann Thorac Surg; 2006 May; 81(5):1851-2. PubMed ID: 16631684 [Abstract] [Full Text] [Related] Page: [Next] [New Search]